Core Biogenesis

| Using plants as biofactories to produce high-value molecules 10 times cheaper.

Growth Factors (GF) are molecules used in the clean meat and cell therapy industries. Both industries suffer from the same problem: the sky-high cost of GF at 2M€/g.

With the GF market predicted to grow by 1-2 orders of magnitude in the next 3-5 years, this is a massive opportunity.

At Core Biogenesis, we use plants as biofactories to produce GF 10x cheaper.

We use proprietary gene editing and plant biotechnology to drastically reduce the cost of making GF. 

We have already signed a €250k contract with a pharmaceutical company and we have in our pipeline more than 15 companies waiting to test our molecules in our pipeline.

Chouaib Meziadi (left) and Alexandre Reeber (right)

Chouaib Meziadi (left) and Alexandre Reeber (right)

Alexandre Reeber, CEO and co-founder

Alexandre has a background in Biotechnology and Neuroscience, and experience as a project manager in the neurotechnology space.

Chouaib Meziadi, CTO and co-founder

Chouaib holds a PhD in Plant Genetics from Université Paris-Saclay, and a postdoc in plant Epigenetics, with 10 peer-reviewed papers.